Skip to main content
. 2004 Jul 19;2004(3):CD001720. doi: 10.1002/14651858.CD001720.pub2

Leong 1989.

Methods Allocation: randomised. 
 Blindness: partial. 
 Duration: 28 weeks.
Participants Diagnosis: schizophrenia (ICD‐295). 
 History: informed consent given. 
 N=60. 
 Age: mean 38 years, range 18‐65. 
 Sex: 27M, 33F. 
 Setting: community.
Interventions 1. Pipothiazine palmitate: dose range 25‐50 mg/IM/frequency not reported. N=30. 
 2. Fluphenazine decanoate: dose range 12.5‐50 mg/IM/frequency not reported. N=30.
Outcomes Global Impression: CGI. 
 Leaving the study early. 
 Additional medication. 
 Adverse effects: checklist, EPS.
Unable to use ‐ 
 Mental state: BPRS (no usable data).
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear